End-of-day quote
Korea S.E.
06:00:00 2024-05-09 pm EDT
|
5-day change
|
1st Jan Change
|
13,400
KRW
|
-1.33%
|
|
+1.21%
|
-41.36%
|
Mar. 27 |
Ray Co., Ltd. announced that it has received KRW 25 billion in funding from KB Securities Co., Ltd., L&C Bio Co., Ltd, Samsung Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Hanwha Investment & Securities Co., Ltd.
|
CI
| Mar. 25 |
Ray Co., Ltd. announced that it expects to receive KRW 25 billion in funding from KB Securities Co., Ltd., L&C Bio Co., Ltd, Samsung Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Hanwha Investment & Securities Co., Ltd.
|
CI
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
285,425
|
354,619
|
377,240
|
325,683
|
349,240
|
204,806
|
-
|
-
|
Enterprise Value (EV)
2 |
285.4
|
337.9
|
350.4
|
372.7
|
407.5
|
240.8
|
232.6
|
204.8
|
P/E ratio
|
24.7
x
|
44.9
x
|
-28,350
x
|
44.3
x
|
-163
x
|
17.3
x
|
6.15
x
|
6.38
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
3.91
x
|
6.42
x
|
4.18
x
|
2.52
x
|
2.39
x
|
1.3
x
|
0.91
x
|
0.84
x
|
EV / Revenue
|
3.91
x
|
6.12
x
|
3.88
x
|
2.89
x
|
2.79
x
|
1.53
x
|
1.03
x
|
0.84
x
|
EV / EBITDA
|
18.4
x
|
37.7
x
|
38.5
x
|
16.5
x
|
27.6
x
|
10.2
x
|
4.74
x
|
3.79
x
|
EV / FCF
|
60.1
x
|
-176
x
|
-33.8
x
|
-10.2
x
|
-16.2
x
|
8.3
x
|
9.02
x
|
11.4
x
|
FCF Yield
|
1.66%
|
-0.57%
|
-2.96%
|
-9.85%
|
-6.16%
|
12%
|
11.1%
|
8.79%
|
Price to Book
|
4.96
x
|
5.43
x
|
3.93
x
|
2.88
x
|
2.74
x
|
1.68
x
|
1.2
x
|
1.21
x
|
Nbr of stocks (in thousands)
|
13,307
|
13,307
|
13,307
|
13,627
|
15,284
|
15,284
|
-
|
-
|
Reference price
3 |
21,450
|
26,650
|
28,350
|
23,900
|
22,850
|
13,400
|
13,400
|
13,400
|
Announcement Date
|
2/11/20
|
2/9/21
|
2/18/22
|
2/14/23
|
2/15/24
|
-
|
-
|
-
|
1KRW in Million2KRW in Billions3KRW Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
73.07
|
55.2
|
90.34
|
129
|
145.9
|
157
|
225.4
|
243
|
EBITDA
1 |
15.47
|
8.959
|
9.099
|
22.54
|
14.74
|
23.5
|
49.08
|
54
|
EBIT
1 |
12.86
|
4.581
|
3.401
|
16.21
|
6.118
|
16
|
41.35
|
45
|
Operating Margin
|
17.6%
|
8.3%
|
3.76%
|
12.56%
|
4.19%
|
10.19%
|
18.34%
|
18.52%
|
Earnings before Tax (EBT)
1 |
13.28
|
8.865
|
-2.751
|
11.47
|
-4.154
|
16.5
|
40.5
|
45
|
Net income
1 |
11.27
|
7.904
|
0.0531
|
7.957
|
-3.733
|
12.5
|
33.3
|
35
|
Net margin
|
15.42%
|
14.32%
|
0.06%
|
6.17%
|
-2.56%
|
7.96%
|
14.77%
|
14.4%
|
EPS
2 |
868.4
|
594.0
|
-1.000
|
539.0
|
-140.0
|
774.5
|
2,178
|
2,099
|
Free Cash Flow
3 |
4,745
|
-1,920
|
-10,364
|
-36,694
|
-25,083
|
29,000
|
25,800
|
18,000
|
FCF margin
|
6,494.4%
|
-3,478.09%
|
-11,472.59%
|
-28,445.39%
|
-17,193.88%
|
18,471.34%
|
11,444.29%
|
7,407.41%
|
FCF Conversion (EBITDA)
|
30,672.87%
|
-
|
-
|
-
|
-
|
123,404.26%
|
52,572.59%
|
33,333.33%
|
FCF Conversion (Net income)
|
42,106.61%
|
-
|
-
|
-
|
-
|
232,000%
|
77,477.48%
|
51,428.57%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/11/20
|
2/9/21
|
2/18/22
|
2/14/23
|
2/15/24
|
-
|
-
|
-
|
1KRW in Billions2KRW3KRW in Million Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
25.16
|
26.58
|
17.63
|
31.16
|
32.99
|
47.22
|
20.02
|
39.36
|
38.54
|
47.96
|
28.5
|
33.1
|
39.3
|
54.5
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
4.531
|
-6.415
|
-0.9331
|
3.332
|
4.242
|
9.565
|
-4.316
|
3.331
|
4.008
|
3.095
|
3.3
|
3.9
|
2.3
|
4
|
Operating Margin
|
18.01%
|
-24.13%
|
-5.29%
|
10.69%
|
12.86%
|
20.25%
|
-21.55%
|
8.46%
|
10.4%
|
6.45%
|
11.58%
|
11.78%
|
5.85%
|
7.34%
|
Earnings before Tax (EBT)
1 |
6.332
|
-10.78
|
-
|
-
|
3.984
|
8.448
|
-
|
-
|
3.92
|
-7.146
|
1.9
|
4.1
|
10.2
|
18.9
|
Net income
1 |
5.213
|
-8.088
|
-
|
-
|
2.497
|
5.497
|
-2.864
|
1.331
|
3.554
|
-4.167
|
2.5
|
1.6
|
3.7
|
2.7
|
Net margin
|
20.72%
|
-30.42%
|
-
|
-
|
7.57%
|
11.64%
|
-14.3%
|
3.38%
|
9.22%
|
-8.69%
|
8.77%
|
4.83%
|
9.41%
|
4.95%
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-190.0
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/10/21
|
2/18/22
|
5/13/22
|
7/19/22
|
10/31/22
|
2/14/23
|
5/12/23
|
8/11/23
|
11/13/23
|
2/15/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
47
|
58.2
|
36
|
27.8
|
-
|
Net Cash position
1 |
-
|
16.7
|
26.8
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
2.084
x
|
3.95
x
|
1.532
x
|
0.5665
x
|
-
|
Free Cash Flow
2 |
4,745
|
-1,920
|
-10,364
|
-36,694
|
-25,083
|
29,000
|
25,800
|
18,000
|
ROE (net income / shareholders' equity)
|
27%
|
12.9%
|
-0.02%
|
6.67%
|
-3.03%
|
9.9%
|
16.6%
|
21%
|
ROA (Net income/ Total Assets)
|
19.1%
|
9.53%
|
-0.01%
|
3.98%
|
-1.55%
|
5.1%
|
9.58%
|
11.4%
|
Assets
1 |
59
|
82.93
|
-552.8
|
199.8
|
240.9
|
245.1
|
347.6
|
307
|
Book Value Per Share
3 |
4,324
|
4,907
|
7,217
|
8,300
|
8,327
|
7,957
|
11,204
|
11,041
|
Cash Flow per Share
3 |
500.0
|
-
|
801.0
|
-558.0
|
-1,482
|
2,737
|
3,056
|
2,388
|
Capex
1 |
-
|
4.82
|
21.5
|
31.3
|
2.29
|
14.4
|
23.7
|
22
|
Capex / Sales
|
-
|
8.74%
|
23.84%
|
24.28%
|
1.57%
|
9.17%
|
10.49%
|
9.05%
|
Announcement Date
|
2/11/20
|
2/9/21
|
2/18/22
|
2/14/23
|
2/15/24
|
-
|
-
|
-
|
1KRW in Billions2KRW in Million3KRW Last Close Price
13,400
KRW Average target price
33,400
KRW Spread / Average Target +149.25% Consensus |
1st Jan change
|
Capi.
|
---|
| -41.36% | 150M | | -4.01% | 14.91B | | -35.44% | 2.96B | | -14.59% | 2.41B | | -11.01% | 1.48B | | -.--% | 1.12B | | +58.24% | 583M | | +94.87% | 515M | | +12.77% | 244M | | +0.12% | 230M |
Medical Imaging Systems
|